Apria extends purchasing contract with Respironics
January 19, 2004
MURRYSVILLE, Pa. - Apria amended its purchasing agreement with Respironics last week and designated the respiratory products manufacturer a shared primary supplier for its lucrative oxygen concentrator business.
Under the terms of the amended contract, which runs through Dec. 31, 2004, Respironics also is a shared primary supplier for all CPAP sleep therapy units and accessories. The company will be the primary supplier for all bi-level and smart CPAP devices for the sleep apnea market and the single source supplier for all infant apnea and sleep diagnostic equipment. Respironics will also continue to be shared primary supplier for volume ventilators.
John Miclot, president and chief executive officer of Respironics stated, "We are extremely pleased that Apria has decided to extend our relationship an additional 12 months. We have a long-standing relationship with Apria and we look forward to being a resource for them with our key products and programs into the future. We will continue to provide the type of innovative solutions that have been the hallmark of Respironics' approach to the sleep and respiratory marketplaces."
Respironics stated that it will not be changing its financial outlook or guidance for fiscal year 2004 and fiscal year 2005 based on the terms of the Purchasing Agreement Amendment.